4-(2-(4-(adamantan-1-yl)phenoxy)acetyl)-1-methylpiperazin-1-ium hydrogensulfate | 1429054-90-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 4-(2-(4-(adamantan-1-yl)phenoxy)acetyl)-1-methylpiperazin-1-ium hydrogensulfate
• 英文别名: 4-(2-(4-(Adamantan-1-yl)phenoxy)acetyl)-1-methylpiperazin-1-ium hydrogensulfate；2-[4-(1-adamantyl)phenoxy]-1-(4-methylpiperazin-4-ium-1-yl)ethanone;hydrogen sulfate
• CAS: 1429054-90-9
• 化学式: C₂₃H₃₂N₂O₂*H₂O₄S
• 分子量: 466.599
• InChiKey: IQAQDJXTKUFNJS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.65
• 重原子数：
  32
• 可旋转键数：
  4
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.7
• 拓扑面积：
  120
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  化合物IDF-11774 在 硫酸 作用下， 以 丙酮 为溶剂， 反应 3.0h， 以85%的产率得到4-(2-(4-(adamantan-1-yl)phenoxy)acetyl)-1-methylpiperazin-1-ium hydrogensulfate
  参考文献：
  名称：

  NOVEL COMPOUNDS AS HIF-1ALPHAINHIBITORS AND MANUFACTURING PROCESS THEREOF

  摘要：

  本发明涉及作为HIF-1α抑制剂的新化合物，其制造工艺以及药物组合物。根据本发明的化合物具有对HIF-1α的抑制活性，可用作治疗预防和/或治疗各种实体癌症，如结肠癌、肝癌、胃癌和乳腺癌。此外，根据本发明的化合物在治疗由HIF-1α介导的VEGFA表达加重的糖尿病视网膜病变和类风湿性关节炎方面具有用处。

  公开号：

  US20140228357A1
• 作为试剂：
  描述：

  化合物IDF-11774 、 硫酸 在 4-(2-(4-(adamantan-1-yl)phenoxy)acetyl)-1-methylpiperazin-1-ium hydrogensulfate 作用下， 生成 4-(2-(4-(adamantan-1-yl)phenoxy)acetyl)-1-methylpiperazin-1-ium hydrogensulfate
  参考文献：
  名称：

  NOVEL COMPOUNDS AS HIF-1ALPHAINHIBITORS AND MANUFACTURING PROCESS THEREOF

  摘要：

  本发明涉及一种新型的HIF-1α抑制剂化合物，其制备方法和药物组合物。本发明的化合物具有对HIF-1α的抑制活性，可用于治疗和/或预防各种实体癌症，如结肠癌、肝癌、胃癌和乳腺癌。此外，本发明的化合物还可用于治疗由HIF-1α介导的VEGFA表达加剧的糖尿病视网膜病变和类风湿性关节炎。

  公开号：

  US20140228357A1

文献信息

• NOVEL COMPOUNDS AS HIF-1 ALPHA INHIBITORS AND MANUFACTURING PROCESS THEREOF
  申请人：DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION

  公开号：US20160193215A1

  公开（公告）日：2016-07-07

  The present invention relates to novel compounds as HIF-1α inhibitors, manufacturing process thereof, and a pharmaceutical compositions. The compounds according to the present invention having inhibition activity against HIF-1α, can be used as a therapeutic prevention and/or treatment for various solid cancers such as colon cancer, liver cancer, stomach cancer and breast cancer. Also, the compounds according to the present invention are useful in the treatment of diabetic retinopathy and rheumatoid arthritis, which are aggravated by HIF-1α-mediated VEGFA expression.

  本发明涉及一种新型化合物作为HIF-1α抑制剂，其制造过程以及制药组合物。本发明的化合物具有对HIF-1α的抑制活性，可用于治疗和/或预防各种实体癌症，如结肠癌、肝癌、胃癌和乳腺癌。此外，本发明的化合物对于由HIF-1α介导的VEGFA表达加剧的糖尿病视网膜病变和类风湿性关节炎的治疗也很有用。
• Compounds as HIF-1alphainhibitors and manufacturing process thereof
  申请人：DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION

  公开号：US09315507B2

  公开（公告）日：2016-04-19

  The present invention relates to novel compounds as HIF-1α inhibitors, manufacturing process thereof, and a pharmaceutical compositions. The compounds according to the present invention having inhibition activity against HIF-1α, can be used as a therapeutic prevention and/or treatment for various solid cancers such as colon cancer, liver cancer, stomach cancer and breast cancer. Also, the compounds according to the present invention are useful in the treatment of diabetic retinopathy and rheumatoid arthritis, which are aggravated by HIF-1α-mediated VEGFA expression.

  本发明涉及一种新型化合物作为HIF-1α抑制剂，其制备方法和制备的药物组合物。本发明的化合物具有对HIF-1α的抑制活性，可用于治疗预防和/或治疗各种实体肿瘤，如结肠癌、肝癌、胃癌和乳腺癌。此外，本发明的化合物对于由HIF-1α介导的VEGFA表达加重的糖尿病视网膜病变和类风湿性关节炎的治疗也是有用的。
• NOVEL COMPOUNDS AS HIF-1ALPHA INHIBITORS AND MANUFACTURING PROCESS THEREOF
  申请人：Dongguk University Industry-Academic Cooperation Foundation

  公开号：EP2760823B1

  公开（公告）日：2017-11-08
• NOVEL COMPOUNDS AS HIF-1ALPHAINHIBITORS AND MANUFACTURING PROCESS THEREOF
  申请人：KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY

  公开号：US20140228357A1

  公开（公告）日：2014-08-14

  The present invention relates to novel compounds as HIF-1α inhibitors, manufacturing process thereof, and a pharmaceutical compositions. The compounds according to the present invention having inhibition activity against HIF-1α, can be used as a therapeutic prevention and/or treatment for various solid cancers such as colon cancer, liver cancer, stomach cancer and breast cancer. Also, the compounds according to the present invention are useful in the treatment of diabetic retinopathy and rheumatoid arthritis, which are aggravated by HIF-1α-mediated VEGFA expression.

  本发明涉及作为HIF-1α抑制剂的新化合物，其制造工艺以及药物组合物。根据本发明的化合物具有对HIF-1α的抑制活性，可用作治疗预防和/或治疗各种实体癌症，如结肠癌、肝癌、胃癌和乳腺癌。此外，根据本发明的化合物在治疗由HIF-1α介导的VEGFA表达加重的糖尿病视网膜病变和类风湿性关节炎方面具有用处。